Huayao Li

机构：Weifang Medical University · ORCID：0000-0003-2331-366X

发表论文 64 篇 · 总被引 1822 次 · h-index 27

代表论文

Polysaccharides regulate Th1/Th2 balance: A new strategy for tumor immunotherapy (2023 · Biomedicine & Pharmacotherapy · 被引 124)
Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy (2022 · Biomedicine & Pharmacotherapy · 被引 81)
Flavonoids regulate tumor-associated macrophages – From structure-activity relationship to clinical potential (Review) (2022 · Pharmacological Research · 被引 81)
ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies (2023 · Biomedicine & Pharmacotherapy · 被引 72)
NF-κB inhibitors gifted by nature: The anticancer promise of polyphenol compounds (2022 · Biomedicine & Pharmacotherapy · 被引 71)
Focus on immune checkpoint PD-1/PD-L1 pathway: New advances of polyphenol phytochemicals in tumor immunotherapy (2022 · Biomedicine & Pharmacotherapy · 被引 52)